|
Chang, Ting-Ya; Waxman, David J
|
R01ES024421 |
Res Sq (2024 Jun 26) |
|
2024 |
|
Chang, Ting-Ya; Waxman, David J
|
R01ES024421 |
bioRxiv (2024 Jun 12) |
|
2024 |
|
Karri, Kritika; Waxman, David J
|
R01ES024421 |
RNA (2023 Jul) |
|
2023 |
|
Karri, Kritika; Waxman, David J
|
R01ES024421 |
bioRxiv (2023 Jan 08) |
|
2023 |
|
Karri, Kritika; Waxman, David J
|
R01ES024421 |
Toxicol Appl Pharmacol (2023 Jul 15) |
|
2023 |
|
Shin, Aram; Waxman, David J
|
R01ES024421 |
Toxicol Sci (2022 May 26) |
|
2022 |
|
Goldfarb, Christine N; Karri, Kritika; Pyatkov, Maxim; Waxman, David J
|
R01ES024421 |
Endocrinology (2022 Jul 01) |
|
2022 |
|
Kim, Donghwan; Kim, Bora; Brocker, Chad N; Karri, Kritika; Waxman, David J; Gonzalez, Frank J
|
R01ES024421 |
Mol Cell Endocrinol (2022 Nov 01) |
|
2022 |
|
Goldfarb, Christine N; Waxman, David J
|
R01ES024421 |
BMC Genomics (2021 Mar 24) |
|
2021 |
|
Brocker, Chad N; Kim, Donghwan; Melia, Tisha; Karri, Kritika; Velenosi, Thomas J; Takahashi, S
...
|
R01ES024421 |
Nat Commun (2020 Nov 17) |
|
2020 |
|
Karri, Kritika; Waxman, David J
|
R01ES024421 |
Toxicol Sci (2020 04 01) |
|
2020 |
|
Rampersaud, Andy; Lodato, Nicholas J; Shin, Aram; Waxman, David J
|
R01ES024421 |
Toxicol Sci (2019 Oct 01) |
|
2019 |
|
Matthews, Bryan J; Waxman, David J
|
R01ES024421 |
Elife (2018 May 14) |
|
2018 |
|
Lodato, Nicholas J; Rampersaud, Andy; Waxman, David J
|
R01ES024421 |
Toxicol Sci (2018 07 01) |
|
2018 |
|
Yu, Ai-Ming; Ingelman-Sundberg, Magnus; Cherrington, Nathan J; Aleksunes, Lauren M; Zanger, Ulr
...
|
P30ES005022, P30ES006694, P30ES010126, R01ES024421 |
Acta Pharm Sin B (2017 03) |
|
2017 |
|
Lodato, Nicholas J; Melia, Tisha; Rampersaud, Andy; Waxman, David J
|
R01ES024421 |
Toxicol Sci (2017 09 01) |
|
2017 |
|
Oshida, Keiyu; Waxman, David J; Corton, J Christopher
|
R01ES024421 |
PLoS One (2016) |
|
2016 |
|
Suvorov, Alexander; Waxman, David J
|
R01ES024421 |
Reprod Toxicol (2015 Nov) |
|
2015 |